3,475 reports of this reaction
1.5% of all AZATHIOPRINE reports
#18 most reported adverse reaction
RHEUMATOID ARTHRITIS is the #18 most commonly reported adverse reaction for AZATHIOPRINE, manufactured by Sebela Pharmaceuticals Inc.. There are 3,475 FDA adverse event reports linking AZATHIOPRINE to RHEUMATOID ARTHRITIS. This represents approximately 1.5% of all 237,317 adverse event reports for this drug.
Patients taking AZATHIOPRINE who experience rheumatoid arthritis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RHEUMATOID ARTHRITIS is a less commonly reported adverse event for AZATHIOPRINE, but still significant enough to appear in the safety profile.
In addition to rheumatoid arthritis, the following adverse reactions have been reported for AZATHIOPRINE:
The following drugs have also been linked to rheumatoid arthritis in FDA adverse event reports:
RHEUMATOID ARTHRITIS has been reported as an adverse event in 3,475 FDA reports for AZATHIOPRINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RHEUMATOID ARTHRITIS accounts for approximately 1.5% of all adverse event reports for AZATHIOPRINE, making it a notable side effect.
If you experience rheumatoid arthritis while taking AZATHIOPRINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.